**** PLEASE NOTE CHANGE OF SPEAKER***

Dr. Susan Kasedde currently serves as Senior Advisor and Team Leader on HIV and Adolescents for UNICEF based in New York since November 2009. In this role, she has contributed towards global level evidence generation, technical guidance development, advocacy, global partnership development, and technical assistance towards the global response towards HIV prevention, treatment and care in adolescents aged 10 - 19. Since 2011, on behalf of UNICEF, Susan has coordinated a series of efforts including documentation of global practices in the care of adolescents living with HIV; mathematical modeling with the Futures Institute to assess the impact and cost of scale up of proven high impact HIV prevention, treatment and care interventions within a holistic response, on new HIV infections and AIDS deaths in adolescents; and a systematic review with the London School of Hygiene and Tropical Medicine to confirm evidence on effective approaches for programming to reduce HIV infection, illness and death in adolescents. This work has contributed to stronger advocacy and technical guidelines for programming for adolescents, a group of children previously largely neglected. In 2013, the documentation on adolescents living with HIV was a major contribution to the new WHO guidelines on HIV testing and counseling and care in adolescents. The impact modeling and systematic review are among a series of key papers that will be released in a special supplement on HIV prevention, treatment and care in adolescents at the International AIDS Society Conference in Melbourne, Australia in 2014.

 Susan joined UNICEF having served since 2007 as Regional Adviser with the UNAIDS Regional Office for Eastern & Southern Africa. In that role, she was responsible for coordinating analytic work on the epidemic and response and modes of HIV transmission in several high HIV burden countries, working extensively with government teams and partners in the highest HIV burden countries in the world to use an incidence model to predict the next 1000 new HIV infections and assess alignment of national strategies with the national epidemic. Susan has over 18 years of experience working on adolescents sexual and reproductive health of which 16 of those have been focused on HIV in adolescents. Susan holds a doctorate in Epidemiology and Population Health from the London School of Hygiene & Tropical Medicine, a Masters degree in Public Health from Boston University and Bachelors degrees in Biomedical Science and French. Susan is a national of Uganda and speaks English and French.

Abstract
According to international human rights law, countries have to provide palliative care and pain treatment medications as part of their core obligations under the right to health. The failure to take reasonable steps to ensure that people who suffer pain have access to adequate pain treatment may also result in the violation of the obligation to protect against cruel, inhuman and degrading treatment. The lecture will discuss Human Rights Watch’s research on this issue in India, Ukraine, Senegal, Kenya, and Mexico; our national and international advocacy efforts; and how we evaluate the impact of our work.

Joe Amon, PhD MSPH, is the Director of the Health and Human Rights Division at Human Rights Watch. Since joining Human Rights Watch in 2005, Joe has worked on a wide range of issues including access to medicines; discrimination, arbitrary detention and torture in health settings; censorship and the denial of health information; and the role of civil society in the response to infectious disease outbreaks and environmental health threats. Between January 2009 and June 2013 he oversaw Human Rights Watch's work on disability rights. He is an associate in the department of epidemiology at the Bloomberg School of Public Health at Johns Hopkins University and a lecturer in public and international affairs at Princeton University. In 2012 he was a distinguished visiting lecturer at the Paris School of International Affairs of SciencesPo.            

Abstract
Preventing tobacco addiction is one of the leading ways to prevent fatal disease, yet many nations have declined to take steps against it. In recent years an international legal effort has begun to fill this void. In this lecture Professor Koh, formerly Legal Adviser of the U.S. State Department, will review the various dimensions of the legal campaign that is now underway.

Harold Hongju Koh is Sterling Professor of International Law at Yale Law School. He returned to Yale Law School in January 2013 after serving for nearly four years as the 22nd Legal Adviser of the U.S. Department of State.

Professor Koh is one of the country’s leading experts in public and private international law, national security law, and human rights. He first began teaching at Yale Law School in 1985 and served as its fifteenth Dean from 2004 until 2009. From 2009 to 2013, he took leave as the Martin R. Flug ’55 Professor of International Law to join the State Department as Legal Adviser, service for which he received the Secretary of State's Distinguished Service Award. From 1993 to 2009, he was the Gerard C. & Bernice Latrobe Smith Professor of International Law at Yale Law School, and from 1998 to 2001, he served as U.S. Assistant Secretary of State for Democracy, Human Rights and Labor.

Abstract
The most important post-Nuremberg health-related human right and bioethics principle is informed consent. A series of post-9/11 developments, including quarantine and forced vaccination proposals, "altered standards of care" for disaster responders, eliminating consent for "emergency research," the post-ACA rise of "standard of care research," whole genome screening guidelines for adults and children, and proposals for newborns, gene bank proposals for "broad" or no consent, and the force-feeding of hunger strikers at Guantanamo and in US prisons, all suggest that informed consent should be seen as optional, and judged by a physician-determined standard of care. It's time to kill these zombies, and save the life of informed consent, and thus of the individual person who retains dignity and human rights.

George Annas is the cofounder of Global Lawyers and Physicians, a transnational professional association of lawyers and physicians working together to promote human rights and health.  He has degrees from Harvard College (A.B. economics, '67), Harvard Law School (J.D. '70) and Harvard School of Public Health (M.P.H. '72).

Professor Annas is the author or editor of 18 books on health law and bioethics, including Worst Case Bioethics:  Death, Disaster, and Public Health(2010),Public Health Law (2007),American Bioethics: Crossing Human Rights and Health Law Boundaries(2005),The Rights of Patients(3d ed. 2004),Some Choice: Law, Medicine, and theMarket (1999), Standard of Care: The Law of American Bioethics (l993), and Judging Medicine (1987), and a play entitled Shelley's Brain, that has been presented to bioethics audiences across the U.S. and in Australia. Professor Annas wrote a regular feature on "law and bioethics" for the Hastings Center Report from 1976 to 199l, and a regular feature on "Public Health and the Law" in the American Journal of Public Health from 1982 to 1992 and since 1991 has written a regular feature for the NewEngland Journal of Medicine (“Health Law, Ethics & Human Rights”).

He  is a fellow of the American Association for the Advancement of Science, a member of the Institute of Medicine, a member of the National Academies’ Human Rights Committee, and co-chair of the American Bar Association's Committee on Health Rights and Bioethics (Individual Rights and Responsibilities Section). He has also held a variety of government regulatory posts, including Vice Chair of the Massachusetts Board of Registration in Medicine, Chair of the Massachusetts Health Facilities Appeals Board, and Chair of the Massachusetts Organ Transplant Task Force.

Abstract:

Nipah virus lives in large fruit bats in South and Southeast Asia. When people become infected with Nipah virus over half of them die. Nipah virus can also be transmitted from person to person. This talk will describe how this bat virus occasionally infects human populations and causes outbreaks through person-to-person transmission. It will explore the risk of a global pandemic of Nipah virus and consider appropriate policy responses.

Speaker bio:

Stephen Luby is Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine; Deputy Director for Research at the Center for Global Health Innovation; Senior Fellow at the Woods Institute for the Environment and Senior Fellow at the Freeman Spogli Institute for International Studies at Stanford University.

Dr. Luby studied philosophy and earned a Bachelor of Arts summa cum laude from Creighton University. Dr. Luby earned his medical degree from the University of Texas Southwestern Medical School at Dallas and completed his residency in internal medicine at the University of Rochester-Strong Memorial Hospital. He studied epidemiology and preventive medicine at the Centers for Disease Control and Prevention.

Dr. Luby's former positions include leading the Epidemiology Unit of the Community Health Sciences Department at the Aga Khan University in Karachi, Pakistan for 5 years and working as a Medical Epidemiologist in the Foodborne and Diarrheal Diseases Branch of the Centers for Disease Control and Prevention exploring causes and prevention of diarrheal disease in settings where diarrhea is a leading cause of childhood death.  Immediately prior to his current appointment, Dr. Luby served for eight years at the International Centre for Diarrheal Diseases Research, Bangladesh (ICDDR,B), where he directed the Centre for Communicable Diseases. Dr. Luby was seconded from the US Centers for Disease Control and Prevention (CDC) and was the Country Director for CDC in Bangladesh.

Dr. Luby's research has focused on clarifying the burden of several communicable diseases in low income countries and developing and evaluating practical strategies to mitigate their impact. He is currently exploring circumstances where economic and political forces encourage environmental degradation that exerts substantial disease burden in low income countries, with a view to developing and evaluating interventions.

Africa (Proceedings of the National Academy of Sciences 2013): USAID and the UN's World Food Program have proposed strategies for allocating ready-to-use (therapeutic and supplementary) foods to children in developing countries. Analysis is needed to investigate whether there are better alternatives. We use a longitudinal data set of 5657 children from Bwamanda to construct a statistical model that tracks each child's height and weight  throughout the first five years of life. We embed this model into an optimization framework that chooses which individual children should receive food based on a child's sex, age, height and weight, to minimize the mean number of disability-adjusted life years per child subject to a budget constraint. Our proposed policy compares favorably to those proposed by the aid groups. Time permitting, we will also discuss a recent analysis of a nutrition program in Guatemala that quantifies the age dependence in the impact of supplementary food, and develops a food allocation policy that exploits this age dependence and reduces child stunting.

India: Motivated by India's nationwide biometric program for social inclusion, we analyze verification (i.e., one-to-one matching) in the case where we possess 12 similarity scores (for 10 fingerprints and two irises) between a resident's biometric images at enrollment and his biometric images during his first verification. At subsequent verifications, we allow individualized strategies based on these 12 scores: we acquire a subset of the 12 images, get new scores for this subset that quantify the similarity to the corresponding enrollment images, and use the likelihood ratio to decide whether a resident is genuine or an imposter. Compared to the policy currently used in India, our proposed policy provides a five-log (i.e., 100,000-fold) reduction in the false reject rate while only increasing the mean delay from 31 to 38 seconds.

A full speaker bio is available on CISAC's website.